Fortis Group Advisors LLC Sells 3,209 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Fortis Group Advisors LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 53.1% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,833 shares of the healthcare conglomerate's stock after selling 3,209 shares during the quarter. Fortis Group Advisors LLC's holdings in UnitedHealth Group were worth $1,484,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Financial Management Professionals Inc. raised its position in shares of UnitedHealth Group by 0.8% in the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock valued at $1,165,000 after buying an additional 17 shares in the last quarter. Richwood Investment Advisors LLC raised its position in UnitedHealth Group by 0.4% during the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock valued at $2,654,000 after purchasing an additional 20 shares in the last quarter. Global Wealth Strategies & Associates raised its position in UnitedHealth Group by 28.6% during the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock valued at $47,000 after purchasing an additional 20 shares in the last quarter. Kolinsky Wealth Management LLC raised its position in UnitedHealth Group by 1.0% during the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock valued at $1,080,000 after purchasing an additional 21 shares in the last quarter. Finally, Retirement Planning Group LLC increased its holdings in shares of UnitedHealth Group by 5.1% during the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock worth $225,000 after buying an additional 21 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Activity

In related news, Director Kristen Gil bought 3,700 shares of the company's stock in a transaction on Thursday, May 15th. The shares were purchased at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the transaction, the director directly owned 3,818 shares of the company's stock, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO John F. Rex purchased 17,175 shares of the stock in a transaction dated Friday, May 16th. The shares were acquired at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the acquisition, the chief financial officer directly owned 203,796 shares of the company's stock, valued at approximately $59,329,091.52. This trade represents a 9.20% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders have acquired 109,408 shares of company stock worth $31,607,768. Insiders own 0.28% of the company's stock.

Analysts Set New Price Targets

UNH has been the topic of several research reports. Baird R W lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, June 11th. Bank of America downgraded shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and cut their price target for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. TD Securities reissued a "hold" rating and issued a $308.00 price target (down from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research report on Wednesday, May 14th. Finally, Wall Street Zen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $414.35.

UnitedHealth Group Stock Performance

NYSE:UNH traded down $4.46 during midday trading on Thursday, reaching $288.03. The stock had a trading volume of 14,738,720 shares, compared to its average volume of 7,770,851. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The stock has a market cap of $261.28 billion, a P/E ratio of 12.06, a P/E/G ratio of 1.42 and a beta of 0.45. The firm has a fifty day simple moving average of $308.39 and a two-hundred day simple moving average of $436.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period in the previous year, the firm posted $6.91 EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 3.07%. The ex-dividend date was Monday, June 16th. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio is 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.